Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment TA1139 11 March 2026 11 March 2026 Durvalumab with gemcitabine and cisplatin for ...

Tislelizumab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer ID6304 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and ...

WIRED is obsessed with what comes next. Through rigorous investigations and game-changing reporting, we tell stories that don’t just reflect the moment—they help create it. When you look back in 10, ...